On December 2, 2024, Daniel Moorhead, the Chief Financial Officer of Zynex Inc (ZYXI, Financial), executed a sale of 10,000 shares of the company. Following this transaction, the insider now holds 35,190 shares of Zynex Inc. The details of this transaction can be found in the SEC Filing.
Zynex Inc is a company that specializes in the development, manufacturing, and marketing of medical devices for pain management and rehabilitation. The company operates in the healthcare sector, providing innovative solutions to improve patient care.
Over the past year, Daniel Moorhead has sold a total of 35,000 shares and has not made any purchases. The insider transaction history for Zynex Inc indicates that there has been 1 insider buy and 8 insider sells over the same period.
On the day of the recent sale, shares of Zynex Inc were trading at $8.08, giving the stock a market cap of $258.904 million. The company's price-earnings ratio stands at 58.07, which is higher than the industry median of 19.785 and also higher than the company’s historical median price-earnings ratio.
With a trading price of $8.08 and a GF Value of $13.38, Zynex Inc has a price-to-GF-Value ratio of 0.6, indicating that the stock is significantly undervalued based on its GF Value. The GF Value is an intrinsic value estimate developed by GuruFocus, calculated using historical multiples such as price-earnings ratio, price-sales ratio, price-book ratio, and price-to-free cash flow. It also considers a GuruFocus adjustment factor based on the company’s past returns and growth, along with future estimates of business performance from Morningstar analysts.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
